Stockreport

What Celcuity (CELC)'s Gedatolisib Phase 3 Progression-Free Survival Data Means For Shareholders [Yahoo! Finance]

Celcuity Inc.  (CELC) 
Last celcuity inc. earnings: 3/12 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: celcuity.com/home/investors
PDF advanced breast cancer showed gedatolisib-based regimens meaningfully extended progression-free survival versus fulvestrant alone. The data highlight gedatolisib's dif [Read more]